Siemens Healthineers introduced right now its choices for mind well being analysis are increasing, with the brain-derived, absolutely automated Atellica IM Phosphorylated tau 217 (pTau217) and Atellica IM Mind Derived Tau (BDTau) assays now out there for 1. Yearly, there are almost 10 million new instances of dementia recognized worldwide2. Alzheimer’s illness is the most typical, contributing to 60-70 % of instances, although it impacts many extra folks over time as these people turn into adversely impacted and more and more depending on others for his or her care2.
The blood exams from Siemens Healthineers provide researchers chemiluminescent immunoassays to offer a quantitative measurement of brain-derived phosphorylated tau 217 (p-tau217) and Mind Derived Tau (BD tau) and are run on the broadly put in Atellica Answer IM and Atellica CI Analyzers. Blood-based biomarker testing gives a less-invasive methodology in comparison with cerebrospinal fluid which requires a lumbar puncture.
Siemens Healthineers is laser centered on increasing researchers’ entry to blood testing that may cut back the burden of invasive testing to higher perceive these illnesses and assist handle the rising societal impression of neurodegenerative circumstances. Our Atellica IM instrument allows the excessive sensitivity required to detect neurological biomarkers in blood.”
Jim Freeman, Head of Core Laboratory Options R&D for Diagnostics, Siemens Healthineers
“Analyzer engineering is essential for amplifying the sign we have to obtain dependable outcomes utilizing blood exams,” stated Henrik Zetterberg, MD, PhD, an internationally famend neuroscientist recognized for his pioneering analysis on biomarkers of Alzheimer’s illness and different neurodegenerative issues. “Blood exams are a lot simpler for each sufferers and docs – you possibly can scale testing, observe sufferers, or maybe put together a biomarker portfolio.”
Contributions to scientific innovation
Siemens Healthineers is concerned in a number of analysis collaborations to advance earlier detection and characterization of neurological illnesses with p-tau217 and BD tau biomarkers3-5. Notably, multi-cohort analysis research are underway with PREDICTOM, ACCESS-AD, and Banner Solar Well being Analysis Institute.
“We worth the chance to work with the main diagnostics corporations to advance the combat towards Alzheimer’s illness, and it is a nice instance,” stated Nicholas Ashton, PhD, senior director of the Fluid Biomarker Program at Banner Solar Well being Analysis Institute in Arizona. “We’re working to validate the medical utility of the plasma p-tau217 biomarker throughout various affected person populations to advance early detection of Alzheimer’s illness. Our findings seem to help the promise of this Alzheimer’s blood biomarker within the medical setting. We look ahead to additional advancing this analysis.”
Different mind well being biomarkers
Along with the Atellica IM pTau217 and Atellica IM BDTau RUO assays, Siemens Healthineers gives a assay (with CE mark)6 to assist predict the danger of future A number of Sclerosis illness exercise. Growth efforts are underway to supply extra biomarkers, together with Apolipoprotein E-ε4 (ApoE-ε4), a protein concerned within the metabolism of fat and a subtype that’s implicated in Alzheimer’s illness and cardiovascular illnesses. Researchers can keep up to date about these choices
